Factor | Aarestrup_2001_AntAgeandChe (10215)

Antimicrobial Ban

Swine | Grower-finisher

7

Description

Compares before (1995) vs after (2000) changes in the antimicrobials authorized for use in growth promotion in Denmark, due to various bans/voluntary withdrawal of use of one or more agents (for specific amounts used (kg) from 1994-2000, see Table 1).

Resistance Outcomes

Resistance Microbe Outcome
Avilamycin
/
Enterococcus faecium
See: Table 3 AMR+ (%) AMR- (%) Total (n)
1995 (More Use) 0.00 10
2000 (Less Use) 0.00 182
Erythromycin
/
Enterococcus faecium
See: Table 3 AMR+ (%) AMR- (%) Total (n)
1995 (More Use) 80.00 10
2000 (Less Use) 46.70 182
Vancomycin
/
Enterococcus faecium
See: Table 3 AMR+ (%) AMR- (%) Total (n)
1995 (More Use) 20.00 10
2000 (Less Use) 6.00 182
Virginiamycin
/
Enterococcus faecium
See: Table 3 AMR+ (%) AMR- (%) Total (n)
1995 (More Use) 60.00 10
2000 (Less Use) 22.50 182
Avilamycin
/
Enterococcus faecalis
See: Table 3 AMR+ (%) AMR- (%) Total (n)
1995 (More Use) 0.00 49
2000 (Less Use) 0.50 196
Erythromycin
/
Enterococcus faecalis
See: Table 3 AMR+ (%) AMR- (%) Total (n)
1995 (More Use) 93.90 49
2000 (Less Use) 28.10 196
Vancomycin
/
Enterococcus faecalis
See: Table 3 AMR+ (%) AMR- (%) Total (n)
1995 (More Use) 0.00 49
2000 (Less Use) 0.00 196